相关实验视频
Updated: May 11, 2026

09:06
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
14.5K
一步一步的超pH敏感小胞克服pKa阻碍系统性淋巴结输送的障碍
Zachary T Bennett1,2, Gang Huang1, Michael T Dellinger3,4
1Department of Pharmacology, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
ACS nano
|June 20, 2024
概括
设计纳米颗粒用于输入淋巴结的静脉输送是具有挑战性的. 这项研究表明,针对特定pH值的超pH敏感 (UPS) 粒细胞,如UPS5.3,可以改善淋巴结的输送,从而使疾病的检测成为可能.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 已经确定了局部纳米粒子向淋巴结的输送,但对整个淋巴结网络的静脉输送需要进一步调查.
- 通过静脉注射设计纳米粒子以有效向淋巴结,这面临着重大挑战.
研究的目的:
- 为了研究纳米粒子pH过渡性质对向静脉注射后整个淋巴结谱的影响.
- 开发和评估用于增强淋巴结传递和疾病检测的新型纳米粒子策略.
主要方法:
- 利用了具有不同pH过渡值 (pKa 6.9,6.2,5.3) 的超pH敏感 (UPS) 聚合物微粒库.
- 在静脉注射后评估了不同UPS微粒的淋巴结向效率.
- 研究了优化UPS菌根的淋巴结积累机制,包括淋巴和巨细胞相互作用.
- 设计了一个联合组装的纳米粒子 (HyUPS),将UPS6.9和UPS5.3结合起来,以克服pH值限制.
主要成果:
- 淋巴结向效率取决于菌体的pH过渡值,UPS5.3显示有效的传递.
- UPS5.3微粒积聚在淋巴结淋巴体中,并依靠淋巴结居民巨细胞进行向.
- 该HyUPS联合组装纳米粒子成功地改善了UPS6.9向淋巴结的传递.
- 开发的纳米粒子平台展示了检测淋巴结转移的潜力.
结论:
- 纳米颗粒的pH敏感性是通过静脉输送实现广泛淋巴结向的关键设计参数.
- HyUPS纳米粒子平台增强了对淋巴结的输送,并有望用于疾病检测中的应用,例如淋巴结转移.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

